Polymeric organoiron compounds with carcinostatic properties (branched hydrazone linkers)
The insufficient efficaciousness of most currently used anticancer drugs has prompted worldwide efforts to reduce toxic and resistance effects, improve overall bioavailability, and widen the therapeutic window. A particularly promising technology to this end rests on the concept of polymer-drug conj...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2011
|
| Online Access: | http://hdl.handle.net/10539/9920 |